Barclays Trims Privia Health Group (NASDAQ:PRVA) Target Pric

Privia Health Group (NASDAQ:PRVA – Free Report) had its target price decreased by Barclays from $22.00 to $19.00 in a research report sent to investors on Monday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock. PRVA has been the subject of a number of other reports. Bank of America cut […]

Related Keywords

United States , America , David Mountcastle , Thomas Bartrum , Vanguard Group Inc , Privia Health Group Price Performance , Unisuper Management Pty Ltd , Jefferies Financial Group , Analyst Recommendations For Privia Health Group , Privia Health Group Company Profile , Bellevue Group , Privia Health Group Inc , Covestor Ltd , First Light Asset Management , Canaccord Genuity Group , News Ratings For Privia Health Group Daily , Barclays , Securities Exchange Commission , Privia Health Group , Free Report , Financial Group , Moderate Buy , Health Group , Get Free Report , Exchange Commission , Light Asset Management , Super Management Pty Ltd , Vanguard Group , Privia Health Group Daily ,